Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
$0.10
$0.12
$0.06
$0.30
$5.58M0.3415,556 shs2 shs
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$4.44
-7.9%
$5.63
$4.29
$14.44
$3.95M1.44320,233 shs13,525 shs
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$0.29
+16.1%
$0.44
$0.24
$5.73
$1.97M0.171.08 million shs9.80 million shs
Vaso Co. stock logo
VASO
Vaso
$0.28
+3.7%
$0.30
$0.19
$0.37
$51.98M2.03121,507 shs27,841 shs
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
$0.00
$0.00
$0.00
$0.11
$3K0.082,455 shs1,030 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
0.00%+0.50%-18.05%-31.03%-56.52%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-6.72%-12.77%-20.43%-34.90%-51.92%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
+14.64%+10.98%-29.51%-40.56%-93.63%
Vaso Co. stock logo
VASO
Vaso
-0.04%-6.58%-6.70%-2.02%+16.63%
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
0.00%+50.00%+50.00%+50.00%-99.40%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
1.061 of 5 stars
3.53.00.00.00.00.00.6
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/AN/AN/AN/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/AN/AN/AN/A
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
3.00
Buy$54.501,127.48% Upside
Nuwellis, Inc. stock logo
NUWE
Nuwellis
2.00
HoldN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/A
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/AN/A

Current Analyst Ratings

Latest VASO, VIVE, NUWE, GTHP, and HSDT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/5/2024
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$24.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
$100K55.76N/AN/A($0.13) per share-0.77
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$640K6.17N/AN/A$3.32 per share1.34
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$8.86M0.22N/AN/A$0.53 per share0.55
Vaso Co. stock logo
VASO
Vaso
$81.02M0.64$0.03 per share9.34$0.14 per share2.00
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
$6.83M0.00N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
-$3.49MN/A0.00N/AN/AN/A-158.84%5/13/2024 (Estimated)
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$8.85M-$14.46N/AN/AN/A-1,374.22%-221.11%-86.23%5/9/2024 (Estimated)
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$20.21M-$13.46N/AN/AN/A-227.99%-218.79%-140.88%5/14/2024 (Estimated)
Vaso Co. stock logo
VASO
Vaso
$4.80M$0.039.34N/A5.93%19.02%6.59%5/13/2024 (Estimated)
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
-$22.03MN/A0.00N/AN/AN/AN/AN/A

Latest VASO, VIVE, NUWE, GTHP, and HSDT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
Vaso Co. stock logo
VASO
Vaso
N/A$0.01+$0.01$0.01N/A$21.92 million
3/28/2024Q4 2023
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$4.05-$1.47+$2.58-$1.47$0.18 million$0.13 million
3/5/202412/31/2023
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$1.39-$2.24-$0.85-$2.24N/A$2.55 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/AN/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/A
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
N/A
0.29
0.16
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/A
3.96
3.72
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/A
2.59
1.96
Vaso Co. stock logo
VASO
Vaso
N/A
1.50
1.45
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
9.69%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
18.63%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
3.13%
Vaso Co. stock logo
VASO
Vaso
N/A
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/A

Insider Ownership

CompanyInsider Ownership
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
66.83%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
7.30%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
0.88%
Vaso Co. stock logo
VASO
Vaso
44.56%
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
5.73%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Guided Therapeutics, Inc. stock logo
GTHP
Guided Therapeutics
455.76 million18.49 millionNot Optionable
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
26890,000822,000Not Optionable
Nuwellis, Inc. stock logo
NUWE
Nuwellis
596.80 million6.74 millionNot Optionable
Vaso Co. stock logo
VASO
Vaso
300185.63 million102.91 millionNot Optionable
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
4710.72 million10.11 millionNot Optionable

VASO, VIVE, NUWE, GTHP, and HSDT Headlines

SourceHeadline
5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 20285-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028
finance.yahoo.com - April 17 at 6:28 PM
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTLInMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
finance.yahoo.com - April 15 at 7:58 AM
Viveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, PredictionsViveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, Predictions
benzinga.com - February 23 at 10:31 AM
The Best Medical Billing Services of 2024The Best Medical Billing Services of 2024
business.com - January 19 at 10:31 PM
VIVE Viveve Medical, Inc.VIVE Viveve Medical, Inc.
seekingalpha.com - July 29 at 9:53 AM
InMode Expands Womens Health and Wellness Market Footprint through Acquisition of Viveve PatentsInMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents
finance.yahoo.com - July 25 at 9:01 AM
VIVE - Viveve Medical, Inc.VIVE - Viveve Medical, Inc.
uk.finance.yahoo.com - June 14 at 7:59 PM
Viveve Medical, Inc. (VIVE)Viveve Medical, Inc. (VIVE)
finance.yahoo.com - February 24 at 8:19 AM
Viveve Medical announces study result from PURSUIT clinical trial to treat female stress urinary incontinenceViveve Medical announces study result from PURSUIT clinical trial to treat female stress urinary incontinence
pharmabiz.com - January 20 at 9:26 AM
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesdays Mid-Day SessionWhy Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
msn.com - January 17 at 3:40 PM
Viveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceViveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
finanznachrichten.de - January 17 at 10:39 AM
Viveve crashes ~60% as company decides to delist, explore sale after trial failsViveve crashes ~60% as company decides to delist, explore sale after trial fails
seekingalpha.com - January 17 at 10:39 AM
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceViveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
finance.yahoo.com - January 17 at 10:39 AM
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence TrialViveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
finance.yahoo.com - January 17 at 10:39 AM
Why Is Viveve Medical (VIVE) Stock Down 69% Today?Why Is Viveve Medical (VIVE) Stock Down 69% Today?
investorplace.com - January 17 at 10:03 AM
Viveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call TranscriptViveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call Transcript
insidermonkey.com - December 29 at 9:56 AM
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits ConcludedViveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
finance.yahoo.com - December 15 at 10:21 AM
Viveve gets US patent for treating female stress urinary incontinenceViveve gets US patent for treating female stress urinary incontinence
pharmabiz.com - December 3 at 7:46 AM
Viveve Medical, Inc.: Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceViveve Medical, Inc.: Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
finanznachrichten.de - December 1 at 12:46 PM
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceViveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
finance.yahoo.com - December 1 at 12:46 PM
Viveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagViveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
finance.yahoo.com - November 13 at 7:01 PM
InvestorNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate UpdateInvestorNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate Update
markets.buffalonews.com - November 12 at 7:52 AM
Viveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateViveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - November 10 at 4:16 PM
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateViveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - November 10 at 4:16 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Guided Therapeutics logo

Guided Therapeutics

OTCMKTS:GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Helius Medical Technologies logo

Helius Medical Technologies

NASDAQ:HSDT
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
Nuwellis logo

Nuwellis

NASDAQ:NUWE
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Vaso logo

Vaso

OTCMKTS:VASO
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.
Viveve Medical logo

Viveve Medical

NASDAQ:VIVE
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.